Address:
Washington, District of Columbia
Type Of Business:
Pharmaceutical Mrketing, Education, Consulting and Pharmaceutical Product Licensing Companies
Expertise:
Strategy, Marketing, Education, Product Planning and Development
Major Product/SVS:
Pharmaceutical Marketing, Education, Licensing
Favorite Business Publication:
Wall Street Journal
Affiliations Awards:
Alliance for Continuing Medical Education; American Board of Respiratory Care, Member Who's Who Worldwide; Sterling Who's Who, International Who's Who Among Top Executives, Marquis Who's Who in Health and Medicine
Highlight of career?:
The highlight of his career was founding a company operating on a new business model, and recently founding a new biopharmaceutical company.
Number Of Years In Profession:
23
Number Of Years In Current Position:
5
What Does He/She Attribute Success To:
He attributes his success to his background in healthcare practice, continuing medical education, and pharmaceutical marketing, and his understanding of the clients' needs.
How Did They Get Involved In Profession:
He became involved in his profession after several years research, and respiratory care practice and continuing education, followed by pharmaceutical marketing, education and strategy planning consulting.
Extended Bio Profile:
Chris Efessiou brings to his clients over 20 years of experience in pharmaceutical marketing, continuing medical education, distance learning, pharmaceutical product management, market research, market planning, pharmaceutical sales and management, and clinical practice in respiratory care and extracorporeal circulation.
Prior to co-founding SRxA, he founded Strategic Implications International (SII), a pharmaceutical marketing and professional education company, which became among the first commercial entities to be accredited by the ACCME as a Continuing Medical Education provider. He co-founded Cogent Interactive Communications, which was later merged with SII. In 1998 SII was acquired and continues to trade to this day under its original name as a division of Cardinal Health. SII was involved in numerous new product launches, primarily in the Respiratory, CNS, and Oncology arenas.
As a product manager at Boehringer Ingelheim Pharmaceuticals, he was responsible for the introduction of numerous line extensions and new product launches in the United States, and the strategic plan for the launch of a Transdermal Therapeutic System globally. While at Boehringer Mannheim Pharmaceuticals, he was responsible for the company's first NDA filing, and numerous licensing and acquisition endeavors.
Prior to his pharmaceutical career, he directed the Continuing Education Division at Newton-Wellesley Hospital , a Tufts Medical School Affiliate, and developed the hospital's first Out-Patient Respiratory Care Clinic. His experience includes clinical practice in Critical Respiratory Care and Extracorporeal Circulation at Brigham and Women's Hospital, and Cardiac Anesthesia Research at the Massachusetts General Hospital in Boston .
He is a graduate of Northeastern University , where he served as a Director of The National Council. He is registered by the American Board for Respiratory Care.